The new new thing (synthetic biology)
It’s fairly clear that nanotechnology is no longer the new new thing. A recent story in Business Week – Nanotech Disappoints in Europe – is not atypical. It takes its lead from the recent difficulties of the UK nanotech company Oxonica, which it describes as emblematic of the nanotechnology sector as a whole: “a story of early promise, huge hype, and dashed hopes.” Meanwhile, in the slightly neophilic world of the think-tanks, one detects the onset of a certain boredom with the subject. For example, Jack Stilgoe writes on the Demos blog “We have had huge fun running around in the nanoworld for the last three years. But there is a sense that, as the term ‘nanotechnology’ becomes less and less useful for describing the diversity of science that is being done, interesting challenges lie elsewhere… But where?”
Source: Soft Machines.